PH22018000417U1 - Monovalent losbanos vaccine against locally prevalent leptospira serovar in the philippines - Google Patents
Monovalent losbanos vaccine against locally prevalent leptospira serovar in the philippinesInfo
- Publication number
- PH22018000417U1 PH22018000417U1 PH22018000417U PH22018000417U PH22018000417U1 PH 22018000417 U1 PH22018000417 U1 PH 22018000417U1 PH 22018000417 U PH22018000417 U PH 22018000417U PH 22018000417 U PH22018000417 U PH 22018000417U PH 22018000417 U1 PH22018000417 U1 PH 22018000417U1
- Authority
- PH
- Philippines
- Prior art keywords
- losbanos
- vaccines
- philippines
- monovalent
- manilae
- Prior art date
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
The present technology relates to processes of preparing leptospirosis vaccines against serovars or serotypes of Leptospira prevalent in the Philippines. Three types of inactivated vaccines were developed based on two identified most prevalent pathogenic Leptospira serovars circulating in the Philippines, namely, Manilae and Losbanos. The vaccines that have been developed are: (1) Monovalent Manilae, (2) Monovalent Losbanos, and (3) Bivalent Manilae and Losbanos (homologous challenge with serovars Manilae and Losbanos and heterochallenge with serovar Grippotyphosa and serovar Canicola). The vaccines that were produced through the developed process were assessed on their safety, immunogenicity and efficiency. The main advantage of these vaccines is their serovar-specificity for the pathogenic Leptospira serovars that are locally prevalent which would ensure an effectively directed program of preventive control of leptospirosis in animals which can be translated to effective leptospirosis prevention among humans.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PH22018000417U PH22018000417U1 (en) | 2018-05-15 | 2018-05-15 | Monovalent losbanos vaccine against locally prevalent leptospira serovar in the philippines |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PH22018000417U PH22018000417U1 (en) | 2018-05-15 | 2018-05-15 | Monovalent losbanos vaccine against locally prevalent leptospira serovar in the philippines |
Publications (2)
Publication Number | Publication Date |
---|---|
PH22018000417Y1 PH22018000417Y1 (en) | 2020-04-22 |
PH22018000417U1 true PH22018000417U1 (en) | 2020-04-22 |
Family
ID=71112225
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH22018000417U PH22018000417U1 (en) | 2018-05-15 | 2018-05-15 | Monovalent losbanos vaccine against locally prevalent leptospira serovar in the philippines |
Country Status (1)
Country | Link |
---|---|
PH (1) | PH22018000417U1 (en) |
-
2018
- 2018-05-15 PH PH22018000417U patent/PH22018000417U1/en unknown
Also Published As
Publication number | Publication date |
---|---|
PH22018000417Y1 (en) | 2020-04-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ595914A (en) | Vaccines comprising attenuated mycoplasma bovis strains and method for the attenuation | |
PE20140576A1 (en) | BOVINE VACCINES AND METHODS | |
NZ591950A (en) | Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition | |
MX2013010620A (en) | Non-pathogenic serotype 4 fowl adenovirus (fadv-4) and viral vector thereof. | |
PH12017501370A1 (en) | Bivalent swine influenza virus vaccine | |
MX2018010958A (en) | Live attenuated zika virus vaccine. | |
BR112015005056A2 (en) | combination vaccines with meningococcus serogroup b and d / t / p | |
CL2016002402A1 (en) | Immunological compositions containing histophilus somni attenuated | |
MY177587A (en) | Multivalent vlp conjugates | |
CL2008003845A1 (en) | Vaccine comprising an emulsion, a bacterin heat-treated at 55-70 ° C for 5-10 hours, comprising a suspension of killed bacteria of the leptospira bratislava species, and from 1 to 13 viruses that cause swine disease. | |
WO2015051371A3 (en) | Haemophilus parasuis vaccine serovar type four | |
MX2022008809A (en) | Porcine reproductive and respiratory syndrome vaccine virus. | |
EA201892003A1 (en) | TREATMENT OF ATOPIC DERMATITIS DOGS | |
PH22018000418Y1 (en) | Monovalent manilae vaccine against locally prevalent leptospira serovar in the philippines | |
PH22018000417U1 (en) | Monovalent losbanos vaccine against locally prevalent leptospira serovar in the philippines | |
PH22018000416Y1 (en) | Bivalent manilae and losbanos vaccine against locally prevalent leptospira serovars in the philippines | |
AR093424A1 (en) | ATTACHED VACCINES OF HAEMOLYTIC MANNHEIMIA AND METHODS FOR THEIR ELABORATION AND USE | |
NZ704204A (en) | Method of providing protective immunity against heterologous leptospira strains | |
BR112017004356A2 (en) | streptococcus agalactiae antigens associated with virulent strains in fish | |
PH12014501688A1 (en) | Influenza c virus and vaccine | |
BR112023019841A2 (en) | VACCINE AGAINST PSEUDRAIVES VIRUS | |
UA115895C2 (en) | Polyvalent fusion protein vaccine against influenza | |
MX2022003090A (en) | Combination vaccine for intradermal administration. | |
CO6160333A2 (en) | BATTERIES TREATED WITH HEAT AND EMULSION VACCINES PREPARED FROM THESE BATTERIES TREATED WITH HEAT | |
MX2021015938A (en) | Porcine reproductive and respiratory syndrome vaccine virus. |